Savara Pharmaceuticals
SVRA
#6601
Rank
$0.54 B
Marketcap
$3.20
Share price
-1.54%
Change (1 day)
-33.05%
Change (1 year)

Savara Pharmaceuticals (SVRA) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $39.46 Million USD

According to Savara Pharmaceuticals's latest financial reports the company's total liabilities are $39.46 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Savara Pharmaceuticals - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$37.19 M16.23%
2022-12-31$31.99 M-0.31%
2021-12-31$32.1 M-3.78%
2020-12-31$33.36 M-3.31%
2019-12-31$34.5 M-21.7%
2018-12-31$44.06 M9.3%
2017-12-31$40.31 M-37.79%
2016-12-31$64.8 M113.69%
2015-12-31$30.32 M156.11%
2014-12-31$11.84 M59.12%
2013-12-31$7.44 M43.68%
2012-12-31$5.17 M2%
2011-12-31$5.07 M181.87%
2010-12-31$1.8 M-23.46%
2009-12-31$2.35 M-50.07%
2008-12-31$4.71 M34.41%
2007-12-31$3.5 M41.18%
2006-12-31$2.48 M-92.1%
2005-12-31$31.45 M2481.29%
2004-12-31$1.21 M647.29%
2003-12-31$0.16 M-83.41%
2002-12-31$0.98 M7.26%
2001-12-31$0.91 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$12.15 M-69.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.85 B 2,060.45%๐Ÿ‡บ๐Ÿ‡ธ USA